United Arab Emirates Dirham

Armenian Dram

Angolan Kwanza

Argentine Peso

Australian Dollar

Azerbaijani Manat

Bosnia and Herzegovina Convertible Mark

Bitcoin Cash

Bangladeshi Taka

Bulgarian Lev

Bahraini Dinar

Bits

Bermudian Dollar

Binance Coin

Bolivian Boliviano

Brazil Real

Bitcoin

Canadian Dollar

Swiss Franc

Chilean Peso

Chinese Yuan

Colombian Peso

Costa Rican Colón

Czech Koruna

Danish Krone

Dominican Peso

Polkadot

Egyptian Pound

Ethiopian Birr

Ether

Euro

British Pound Sterling

Georgian Lari

Ghanaian Cedi

Guatemalan Quetzal

Hong Kong Dollar

Honduran Lempira

Hungarian Forint

Indonesian Rupiah

Israeli New Shekel

Indian Rupee

Icelandic Króna

Jamaican Dollar

Jordanian Dinar

Japanese Yen

Kenyan Shilling

Cambodian Riel

South Korean Won

Kuwaiti Dinar

Kazakhstani Tenge

Lebanese Pound

Chainlink

Sri Lankan Rupee

Litecoin

Moroccan Dirham

Moldovan Leu

Malagasy Ariary

Burmese Kyat

Mexican Peso

Malaysian Ringgit

Nigerian Naira

Norwegian Krone

New Zealand Dollar

Peruvian Sol

Papua New Guinean Kina

Philippine Peso

Pakistani Rupee

Polish Zloty

Romanian Leu

Russian Ruble

Saudi Riyal

Satoshi

Swedish Krona

Singapore Dollar

Solana

Salvadoran Colón

Thai Baht

Turkish Lira

New Taiwan Dollar

Ukrainian hryvnia

Ugandan Shilling

US Dollar

Uruguayan Peso

Uzbekistani Som

Venezuelan bolívar fuerte

Vietnamese đồng

Central African CFA Franc

Silver - Troy Ounce

Gold - Troy Ounce

IMF Special Drawing Rights

Lumens

West African CFA Franc

Yearn.finance

South African Rand

Zambian Kwacha

Alnylam Pharmaceuticals, Inc. is a leading global biopharmaceutical company at the forefront of developing innovative RNA interference (RNAi) therapeutics. The company pioneered the translation of Nobel Prize-winning science into an entirely new class of innovative medicines. Utilizing its proprietary drug delivery technology platforms, Alnylam is dedicated to the R&amp;D, manufacturing, and commercialization of breakthrough small interfering RNA (siRNA) medicines targeting rare diseases, cardiovascular conditions, metabolic disorders, and central nervous system diseases. As an industry pioneer, it possesses a strong core moat in the commercialization and pipeline expansion of gene-silencing technologies.

Alnylam Pharmaceuticals rStock

A list of the top {coinName} markets across all crypto exchanges based on the highest 24h trading volume, with their current price.

A list of the top {coinName} markets across all crypto exchanges based on the highest 24h trading volume, with their current price, filter the pair and see unconverted data.

{base} to {target} Conversion Table

{base} to {target} Price Chart

{name} Price Chart

{name} Historical Data

{name} ({symbol}) financial chart designed for detailed analysis , comparison and more.

{name} ({symbol}) Advanced chart | Coinz.com

{name} to {quoteName} converter - Easily convert {symbol} to {quote} with our free currency convertor

Convert {symbol} to {quote} - {name} to {quoteName} | Coinz.com

Find the latest {name} forecasts from all around the world on our {name} forecasts section.

{name} Forecasts | Coinz.com

View historical {name} price data going back to the start of the cryptocurrency in daily, weekly, or monthly intervals.

{name} ({symbol}) - Historical Data | Coinz.com

{name} ({symbol}) trading pairs across all cryptocurrency exchanges. Check out live rates, prices, and volumes on top crypto exchanges to trade.

{name} ({symbol}) Exchange Markets by Trading Volume | Coinz.com

Our {name} news section keeps you up-to-date with the latest and most relevant {symbol} news from around the world.

{name} ({symbol}) News | Coinz.com

Live {name} ({symbol}) Real-Time Price, Chart, key metrics, tools and more. All you need to know about {name}.

{name} ({symbol}) Price, Chart & Marketcap | Coinz.com

RALNY	USD
0.1	15.92
1	159.21
2	318.42
5	796.05
10	1,592.09
20	3,184.19
50	7,960.47
100	15,920.93
1000	159,209.34

USD	RALNY
0.1	0.00062810385
1	0.00628103855
2	0.01256207710
5	0.03140519275
10	0.06281038551
20	0.12562077102
50	0.31405192756
100	0.62810385512
1000	6.28

Alnylam Pharmaceuticals rStock Converter

RALNY to USD Price Chart

Price Performance

Price Performance

RALNY to USD Conversion Table

Popular Conversions